600479.SHG ZhuZhou QianJin Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
10.88 CNY
Close of Nov 4, 2026
9.20 15.25
Market cap
CNY 5.36B
P/E
14.7x
P/B
1.71x
ROE
11.1%
Dividend yield
2.85%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600479.SHG undervalued?

Graham number
Price10.88
Graham value10.29
Premium5.8%

600479.SHG trades 5.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ZhuZhou QianJin Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for ZhuZhou QianJin Pharmaceutical Co Ltd yet.

ZhuZhou QianJin Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ZhuZhou QianJin Pharmaceutical Co Ltd

ZhuZhou QianJin Pharmaceutical Co.,Ltd engages in the production and sales of Chinese and Western medicines in China. The company offers traditional chinese medicine that cover areas, such as pelvic inflammatory disease, menstrual disorders, cervicitis, dysfunctional uterine bleeding, breast hyperplasia, postpartum blood and qi deficiency, and menopausal syndrome; chemical products that covers areas, including gynecology, cardiovascular system, endocrine system, liver and ki…

Full company profile